Unverified50% confidenceEventExact time
A company announced the acquisition of Orchestra Bio, a platform that helps biopharma teams coordinate complex drug development processes.
1
Sources
50%
Confidence
Short-term (~14 days)
Relevance
10/21/2026
First Seen
Valid until: 11/4/2026
Sources
Related Entities
Related Claims
UnverifiedJoyn Bio is a joint venture between Bayer and Ginkgo Bioworks, exploring the commercialization pathway of engineered microbial symbionts.57% similarUnverifiedSynthetic biology draws on the idea of standardized components from electrical engineering, treating functional modules such as promoters, ribosome binding sites, and coding sequences as reusable BioBricks.56% similarUnverifiedIntero Biosystems' business direction is inferred to be related to biological systems, life sciences, or bioengineering; this inference is based on the literal meaning of the company name, not on confirmed facts.55% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1078752API
curl https://kongchang.com/api/v1/knowledge/claims/1078752MCP
get_claim(id=1078752)